Utah Code 58-37-4.2. Listed controlled substances
Current as of: 2023 | Check for updates
|
Other versions
The following substances, their analogs, homologs, and synthetic equivalents are listed controlled substances:
(1) | AB-001; |
(2) | AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide; |
(3) | AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide; |
(4) | AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide); |
(5) | ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide); |
(6) | ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide); |
(7) | AKB48; |
(8) | alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one); |
(9) | alpha-Pyrrolidinovalerophenone (alpha-PVP); |
(10) | AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone); |
(11) | AM-1248; |
(12) | AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole); |
(13) | AM-2233; |
(14) | AM-679; |
(15) | A796,260; |
(16) | Butylone; |
(17) | CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol); |
(18) | Diisopropyltryptamine (DiPT); |
(19) | Ethylone; |
(20) | Ethylphenidate; |
(21) | Fluoroisocathinone; |
(22) | Fluoromethamphetamine; |
(23) | Fluoromethcathinone; |
(24) | FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate; |
(25) | HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; |
(26) | HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2- methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol; |
(27) | JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone; |
(28) | JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole}; |
(29) | JWH-019; 1-hexyl-3-(1-naphthoyl)indole; |
(30) | JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole}; |
(31) | JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone; |
(32) | JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole); |
(33) | JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole; |
(34) | JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole; |
(35) | JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone; |
(36) | JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole; |
(37) | JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; |
(38) | JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole; |
(39) | MAM-2201; |
(40) | MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone; |
(41) | Methoxetamine; |
(42) | Naphyrone; |
(43) | PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester; |
(44) | Pentedrone; |
(45) | Pentylone; |
(46) | RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole; |
(47) | RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18}; |
(48) | STS-135; |
(49) | UR-144; |
(50) | UR-144 N-(5-chloropentyl) analog; |
(51) | XLR11; |
(52) | 2C-C; |
(53) | 2C-D; |
(54) | 2C-E; |
(55) | 2C-H; |
(56) | 2C-I; |
(57) | 2C-N; |
(58) | 2C-P; |
(59) | 2C-T-2; |
(60) | 2C-T-4; |
(61) | 2NE1; |
(62) | 25I-NBOMe; |
(63) | 2,5-Dimethoxy-4-chloroamphetamine (DOC); |
(64) | 4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate); |
(65) | 4-methylmethcathinone {also known as mephedrone}; |
(66) | 3,4-methylenedioxypyrovalerone {also known as MDPV}; |
(67) | 3,4-Methylenedioxymethcathinone {also known as methylone}; |
(68) | 4-methoxymethcathinone; |
(69) | 4-Methyl-alpha-pyrrolidinopropiophenone; |
(70) | 4-Methylethcathinone; |
(71) | 5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide; |
(72) | 5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate); |
(73) | 5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate); |
(74) | 5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester; |
(75) | 5-Iodo-2-aminoindane (5-IAI); |
(76) | 5-MeO-DALT; |
(77) | 25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; |
(78) | 25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and |
(79) | 25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine. |
Amended by Chapter 26, 2020 General Session